This COVID treatment is almost useless against Omicron BA.2. Why is Canada still using it?

Ireland News News

This COVID treatment is almost useless against Omicron BA.2. Why is Canada still using it?
Ireland Latest News,Ireland Headlines
  • 📰 TheStarPhoenix
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

Sotrovimbab is the latest monoclonal antibody therapy that the pandemic virus has put a partial kibosh to.

that the drug appears capable of causing treatment-resistant mutations in a small number of people.

Once that data is assessed, “the department will communicate the information on our web portal as well as with health-care professionals,” Health Canada said. “Health-care professionals are responsible for making decisions with regard to the best treatment options for their patients considering the local epidemiological context.”Article contentWith SARS-Cov-2, the evolutionary changes have been much more rapid than researchers anticipated, Morris said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

TheStarPhoenix /  🏆 253. in US

Ireland Latest News, Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Omicron sub-variant BA.2 accounts for about 55% of COVID variants in U.S. - CDCOmicron sub-variant BA.2 accounts for about 55% of COVID variants in U.S. - CDCThe U.S. national public health agency said on Tuesday that BA.2 sub-variant of Omicron was estimated to account for more than half the coronavirus variants in the country.
Read more »

Omicron BA.2 Stealth COVID variant now dominant in U.S., CDC data showsOmicron BA.2 Stealth COVID variant now dominant in U.S., CDC data showsThe faster-spreading Omicron sub-variant is now estimated to make up more than half of coronavirus cases in the U.S.
Read more »

BA.2 ‘Stealth Omicron' Subvariant Now the Dominant COVID Strain in the Midwest: CDCBA.2 ‘Stealth Omicron' Subvariant Now the Dominant COVID Strain in the Midwest: CDCAccording to new estimates released Tuesday by the Centers for Disease Control and Prevention, the BA.2 subvariant of COVID-19, otherwise known as “stealth omicron,” is now the dominant strain of the virus in the Midwest and in the United States.
Read more »

Omicron subvariant BA.2 is now the dominant COVID strain in U.S.Omicron subvariant BA.2 is now the dominant COVID strain in U.S.The Omicron subvariant BA.2 accounts for a little over half of all new COVID cases in the U.S. as of Saturday, according to new estimates published by the Centers for Disease Control and Prevention (CDC). The big picture: BA.2 is now the dominant global variant, the World Health Organization (WHO) said last week. CDC Director Rochelle Walensky previously warned it would only be a matter of time before BA.2 became dominant in the U.S. as well.Get market news worthy of your time with Axios Markets
Read more »

Omicron BA.2 Variant Is Dominant Covid-19 Strain in U.S., CDC EstimatesOmicron BA.2 Variant Is Dominant Covid-19 Strain in U.S., CDC EstimatesThe highly contagious strain, which has been causing surges in Europe, now represents more than half of all new U.S. Covid-19 infections, and there are signs of rising caseloads in parts of the Northeast.
Read more »

Houston sees rise in BA.2, COVID omicron subvariant expected to become dominant hereHouston sees rise in BA.2, COVID omicron subvariant expected to become dominant hereHouston is seeing an uptick in the number of BA.2 cases, with genome sequencing and wastewater testing picking up higher levels this week compared to last week.
Read more »



Render Time: 2025-04-10 06:35:15